ArticleJACC. Advances2023
Refined Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension: Initial Results of U.S. Regional Program.
Article in JACC. Advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Safety and Feasibility of Same-Day Discharge After Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: A Single-Center Retrospective Study.Journal of the Society for Cardiovascular Angiography & Interventions · 2026Article
- Conceptual Reconsideration of the Classification of Pulmonary Hypertension: From 5 Groups to 2 Groups.JACC. Asia · 2026Review
- Management of Balloon Pulmonary Angioplasty Complications: An Ounce of Prevention is a Pound of Cure.Journal of the Society for Cardiovascular Angiography & Interventions · 2026Article
- Current Perspectives on Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension.Journal of clinical medicine · 2025Review
- Evolution and New Perspectives of Balloon Pulmonary Angioplasty in CTEPH.Journal of clinical medicine · 2025Review
- Sequelae of Acute Pulmonary Embolism: From Post-Pulmonary Embolism Functional Impairment to Chronic Thromboembolic Disease.Journal of clinical medicine · 2024Review
- Same-Day Discharge Following Outpatient Balloon Pulmonary Angioplasty: A Single-Center Experience.Pulmonary circulation · 2024Article
- The Initial Experience of Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension in Latvia.Medicina (Kaunas, Lithuania) · 2024Article
- Refined balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension - reference center experience.Postepy w kardiologii interwencyjnej = Advances in interventional cardiology · 2024Article
- Reply: "Refined Balloon Pulmonary Angioplasty" May Need to Be Refined.JACC. Advances · 2023Article
- "Refined Balloon Pulmonary Angioplasty" May Need to Be Refined.JACC. Advances · 2023Article
- Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Here to Stay, More to Learn.JACC. Advances · 2023Article
Corrections and comments
- Commented on by
Authors and funding
12 authors.
Funding
Abstract
Objectives: We sought to evaluate the efficacy and safety of refined balloon pulmonary angioplasty (BPA) in the treatment of patients with chronic thromboembolic pulmonary hypertension (CTEPH). Background: BPA is rapidly evolving therapeutic option for patients with nonsurgical CTEPH. There are few US studies that have reported on the outcomes of this novel therapeutic option. Methods: This is a retrospective study of CTEPH patients that underwent BPA at Temple University Hospital. The primary efficacy endpoint was the change in pulmonary vascular resistance (PVR) after BPA as compared to baseline and the primary safety endpoint was the rate of hemoptysis within 24 hours. Secondary endpoints included death, WHO functional class, and 6-minute walk distance (6MWD). We used logistic regression to evaluate factors associated with a hemodynamic and functional response. Results: Conclusion: This single center study from the US showed that BPA with refined techniques in patients with CTEPH was safe and was associated with significant improvements in pulmonary hemodynamics and functional capacity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.